Cellular Therapies Leading to New Treatment Options for Lymphoma Patients - Quiz - MDSpire

Cellular Therapies Leading to New Treatment Options for Lymphoma Patients

A new CAR T-cell consortium, Matthew Cortese, MD, MPH, a hematologic oncologist at Roswell Park Comprehensive Cancer Center, shares that certain types of hard-to-treat lymphomas may be more receptive to immunotherapies than previously thought.

  • June 30, 2025

Share

Original Source(s)

Cellular Therapies Leading to New Treatment Options for Lymphoma Patients

  • June 30, 2025

Related Content

FOXA2 in cancer: from fundamental biology to clinical translation

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases